+41 32 580 0113

info@rhizen.com

October 2020

Home2020 October
Rhizen Pharmaceuticals Announces Out-licensing Agreement
October 8, 2020by userEvents

Rhizen Pharmaceuticals Announces Out-licensing Agreement

Read More
October 5, 2020by userDoctor

Srikant Viswanadha

Pharmacology/Molecular Cell Biology/Toxicology

Read More
Ajit Nair
October 5, 2020by userDoctor

Ajit Nair

23+ years of experience in clinical development and medical affairs in general medicine and oncology dev across different phases of development

Read More
Swaroop Vakkalanka
October 5, 2020by userFounder & CEO

Swaroop Vakkalanka

Multi-scientific team leader in drug discovery and development. Proven track record in best enterprise value creation through successful implementation of R&D strategies

Read More

Cookie Policy

Thank you for visiting this website.
By clicking on “Accept”, you agree to the “Terms and Conditions” for continuing to use the website.

img_box_30_orange

Rhizen Pharmaceuticals AG, Grosspeteranlage 29
4052 Basel Switzerland.
Ph No: +41 32 580 0113

img_box_13

info@rhizen.com​

twitter
linkedin

© 2021 . All Rights Reserved.